Genocea Biosciences Company Profile (NASDAQ:GNCA)

About Genocea Biosciences

Genocea Biosciences logoGenocea Biosciences, Inc. is a biopharmaceutical company. The Company discovers and develops vaccines and immunotherapies. It uses its discovery platform, AnTigen Lead Acquisition System (ATLAS), to design vaccines and immunotherapies that act, in part, through T cell (or cellular) immune responses. The Company operates through business of developing and commercializing vaccines segment. It has one product candidate in Phase II clinical development: GEN-003, which is a therapeutic vaccine or immunotherapy for the treatment of genital herpes infections. It has pre-clinical development programs, which include GEN-001, which is indicated for the treatment of chlamydia prophylaxis, and GEN-002, which indicated for the treatment of genital herpes prophylaxis both of which are in pre-clinical stage of development. The Company's pipeline also includes GEN-005, which is under malaria prophylaxis, Epstein-Barr virus and immuno-oncology programs in research stage of development.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GNCA
  • CUSIP:
Key Metrics:
  • Previous Close: $5.71
  • 50 Day Moving Average: $5.31
  • 200 Day Moving Average: $4.70
  • 52-Week Range: $2.56 - $8.20
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.09
  • P/E Growth: 0.00
  • Market Cap: $161.79M
  • Outstanding Shares: 28,334,000
  • Beta: 1.97
Profitability:
  • Net Margins: -5,121.17%
  • Return on Equity: -47.87%
  • Return on Assets: -38.41%
Debt:
  • Debt-to-Equity Ratio: 0.23%
  • Current Ratio: 20.99%
  • Quick Ratio: 20.99%
Additional Links:
Companies Related to Genocea Biosciences:

Analyst Ratings

Consensus Ratings for Genocea Biosciences (NASDAQ:GNCA) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $21.25 (272.15% upside)
Analysts' Ratings History for Genocea Biosciences (NASDAQ:GNCA)
Show:
DateFirmActionRatingPrice TargetDetails
8/8/2016FBR & CoReiterated RatingBuyView Rating Details
4/1/2016Needham & Company LLCReiterated RatingBuy$15.00View Rating Details
4/1/2016Stifel NicolausBoost Price TargetBuy$11.00 -> $13.00View Rating Details
10/19/2015Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
10/7/2015Cowen and CompanyReiterated RatingBuy$40.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Genocea Biosciences (NASDAQ:GNCA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.44)($0.39)ViewN/AView Earnings Details
5/5/2016Q116($0.42)($0.35)ViewN/AView Earnings Details
2/11/2016Q415($0.40)($0.37)ViewListenView Earnings Details
11/5/2015Q315($0.43)($0.37)ViewListenView Earnings Details
8/6/2015Q215($0.51)($0.43)ViewN/AView Earnings Details
5/7/2015Q115($0.57)($0.64)ViewListenView Earnings Details
2/12/2015Q414($0.55)($0.66)ViewListenView Earnings Details
11/6/2014Q314($0.51)($0.53)ViewN/AView Earnings Details
8/6/2014Q2($0.42)($0.41)ViewN/AView Earnings Details
5/6/2014Q114($0.52)($0.76)$0.26 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Genocea Biosciences (NASDAQ:GNCA)
Current Year EPS Consensus Estimate: $-1.63 EPS
Next Year EPS Consensus Estimate: $-1.85 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.39)($0.39)($0.39)
Q2 20161($0.43)($0.43)($0.43)
Q3 20161($0.44)($0.44)($0.44)
Q4 20161($0.45)($0.45)($0.45)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Genocea Biosciences (NASDAQ:GNCA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Genocea Biosciences (NASDAQ:GNCA)
Insider Ownership Percentage: 19.10%
Institutional Ownership Percentage: 56.49%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2016Jonathan PooleCFOBuy4,000$3.88$15,520.00View SEC Filing  
12/16/2015William D ClarkCEOBuy3,800$6.45$24,510.00View SEC Filing  
9/1/2015Jessica Baker FlechtnerVPSell2,229$11.35$25,299.15View SEC Filing  
6/19/2015Polaris Venture Management Co.Major ShareholderSell30,004$13.04$391,252.16View SEC Filing  
6/17/2015Polaris Venture Management Co.Major ShareholderSell10,618$13.01$138,140.18View SEC Filing  
6/16/2015Polaris Venture Management Co.Major ShareholderSell46,000$13.24$609,040.00View SEC Filing  
6/1/2015Jessica Baker FlechtnerVPSell2,229$10.52$23,449.08View SEC Filing  
5/1/2015Jessica Baker FlechtnerVPSell2,229$10.21$22,758.09View SEC Filing  
4/1/2015Jessica Baker FlechtnerVPSell2,283$11.77$26,870.91View SEC Filing  
3/17/2015Stephen J HoffmanDirectorBuy700,000$8.25$5,775,000.00View SEC Filing  
2/2/2015Jessica Baker FlechtnerVPSell4,699$8.50$39,941.50View SEC Filing  
9/12/2014Jessica Baker FlechtnerVPSell6,435$12.00$77,220.00View SEC Filing  
9/11/2014Paul GiannascaVPSell4,071$11.84$48,200.64View SEC Filing  
9/10/2014Paul GiannascaVPSell834$12.35$10,299.90View SEC Filing  
9/9/2014Paul GiannascaVPSell2,455$12.43$30,515.65View SEC Filing  
9/8/2014Paul GiannascaVPSell2,970$12.80$38,016.00View SEC Filing  
8/29/2014Paul GiannascaVPSell6,760$12.50$84,500.00View SEC Filing  
8/14/2014Polaris Venture Management Co.Major ShareholderSell9,660$13.01$125,676.60View SEC Filing  
8/12/2014Polaris Venture Management Co.Major ShareholderSell63,794$13.28$847,184.32View SEC Filing  
2/10/2014Plc GlaxosmithklineInsiderBuy143,773$12.00$1,725,276.00View SEC Filing  
2/10/2014Polaris Venture Management Co.Major ShareholderBuy232,820$12.00$2,793,840.00View SEC Filing  
2/10/2014Stephen J HoffmanDirectorBuy250,931$12.00$3,011,172.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Genocea Biosciences (NASDAQ:GNCA)
DateHeadline
News IconGenocea Biosciences's “Buy” Rating Reiterated at FBR & Co. (GNCA) - Petro Global News 24 (NASDAQ:GNCA)
petroglobalnews24.com - September 23 at 10:16 AM
News IconGenocea Biosciences Given “Buy” Rating at Needham & Company LLC (GNCA) - Petro Global News 24 (NASDAQ:GNCA)
petroglobalnews24.com - September 22 at 8:19 AM
News IconCowen and Company Reaffirms Buy Rating for Genocea Biosciences (GNCA) - Petro Global News 24 (NASDAQ:GNCA)
petroglobalnews24.com - September 22 at 8:19 AM
News IconEarnings Take Center Stage; Analysts Weighing in on Genocea Biosciences, Inc. (NASDAQ:GNCA) - Frisco Fastball (NASDAQ:GNCA)
friscofastball.com - September 20 at 10:25 AM
News IconAnalysts Take Aim At This Stock's Earnings Estimates: Genocea Biosciences, Inc. (NASDAQ:GNCA) - Frisco Fastball (NASDAQ:GNCA)
friscofastball.com - September 20 at 10:25 AM
News IconWhat are Research Firms Saying About Genocea Biosciences, Inc. (NASDAQ:GNCA)? - Frisco Fastball (NASDAQ:GNCA)
friscofastball.com - September 16 at 5:05 PM
News IconSell-side Consensus Sees Genocea Biosciences, Inc. (NASDAQ:GNCA) Going Where Near-Term? - Frisco Fastball (NASDAQ:GNCA)
friscofastball.com - September 16 at 9:07 AM
News IconAnalysts Take: Genocea Biosciences, Inc. (NASDAQ:GNCA ... - Frisco Fastball (NASDAQ:GNCA)
friscofastball.com - September 16 at 9:07 AM
News IconStock Showing Gains in Today's Session: Genocea Biosciences, Inc. (NASDAQ:GNCA) - Post News (NASDAQ:GNCA)
www.kentuckypostnews.com - September 7 at 5:26 PM
investornewswire.com logoWill Genocea Biosciences, Inc. (NASDAQ:GNCA) Hit $40 Price Target? - Investor Newswire (NASDAQ:GNCA)
www.investornewswire.com - August 22 at 9:53 AM
finance.yahoo.com logoGENOCEA BIOSCIENCES, INC. Financials (NASDAQ:GNCA)
finance.yahoo.com - August 16 at 5:27 PM
smarteranalyst.com logoFBR Chimes in on Genocea Biosciences Inc (GNCA) Following 2Q16 Update - Smarter Analyst (NASDAQ:GNCA)
www.smarteranalyst.com - August 9 at 9:38 PM
finance.yahoo.com logoGenocea Congratulates Jessica Baker Flechtner, Ph.D. for Recognition on 2016’s 40 Women To Watch Over 40 List (NASDAQ:GNCA)
finance.yahoo.com - August 9 at 8:12 AM
publicnow.com logoGenocea Congratulates Jessica Baker Flechtner, Ph.D. for Recognition on 2016's 40 Women To Watch Over 40 List (NASDAQ:GNCA)
www.publicnow.com - August 9 at 8:12 AM
equities.com logoGenocea Biosciences Inc. (GNCA) Jumps 5.54% on August 04 - Equities.com (NASDAQ:GNCA)
www.equities.com - August 6 at 8:07 AM
equities.com logoGenocea Biosciences Inc. (GNCA) Jumps 9.82% on August 05 - Equities.com (NASDAQ:GNCA)
www.equities.com - August 6 at 8:07 AM
twst.com logoGenocea Biosciences Inc.: current report (NASDAQ:GNCA)
www.twst.com - August 4 at 5:33 PM
globenewswire.com logoGenocea Reports Second Quarter 2016 Financial Results (NASDAQ:GNCA)
globenewswire.com - August 4 at 8:10 AM
sg.finance.yahoo.com logoGenocea Biosciences reports 2Q loss (NASDAQ:GNCA)
sg.finance.yahoo.com - August 4 at 8:09 AM
finance.yahoo.com logoGenocea to Host Second Quarter 2016 Financial Results Conference Call & Webcast on August 4, 2016 (NASDAQ:GNCA)
finance.yahoo.com - July 28 at 8:00 AM
investornewswire.com logoIs $40 Price Target Attainable For Genocea Biosciences, Inc. (NASDAQ:GNCA)? - Investor Newswire (NASDAQ:GNCA)
www.investornewswire.com - July 24 at 9:42 AM
ftsenews.co.uk logoNew Broker Ratings For Genocea Biosciences Inc (GNCA) - FTSE News (NASDAQ:GNCA)
www.ftsenews.co.uk - July 22 at 5:10 PM
News IconGenocea Biosciences, Inc. (NASDAQ:GNCA): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:GNCA)
www.engelwooddaily.com - July 22 at 8:10 AM
News IconGenocea Biosciences Incorporated (NASDAQ:GNCA) Shorted Shares Decreased By 10.56% - Consumer Eagle (NASDAQ:GNCA)
www.consumereagle.com - July 21 at 8:50 AM
News IconEquity Roundup: Stock Performance Focus on Genocea Biosciences, Inc. (NASDAQ:GNCA) - Press Telegraph (NASDAQ:GNCA)
presstelegraph.com - July 20 at 8:09 AM
News IconHow Many Genocea Biosciences Inc (NASDAQ:GNCA)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:GNCA)
www.consumereagle.com - July 19 at 5:23 PM
investornewswire.com logoStrong Sell Calls For Genocea Biosciences, Inc. (NASDAQ:GNCA) At 0 - Investor Newswire (NASDAQ:GNCA)
www.investornewswire.com - July 18 at 5:30 PM
News IconShares Experiencing a Downtrend: Genocea Biosciences, Inc. (NASDAQ:GNCA) - TGP (NASDAQ:GNCA)
telanaganapress.com - July 16 at 5:04 PM
News IconAnalyst Target and Average Rating Watch: Genocea Biosciences, Inc. (NASDAQ:GNCA) - Press Telegraph (NASDAQ:GNCA)
presstelegraph.com - July 15 at 8:14 AM
News IconGenocea Biosciences Incorporated (NASDAQ:GNCA) Short Interest Decreased By 4.84% - Consumer Eagle (NASDAQ:GNCA)
www.consumereagle.com - July 15 at 8:14 AM
News IconGenocea Biosciences, Inc. (NASDAQ:GNCA) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:GNCA)
telanaganapress.com - July 13 at 8:08 AM
News IconStock Volatility Focus for: Genocea Biosciences, Inc. (NASDAQ:GNCA) - Engelwood Daily (NASDAQ:GNCA)
www.engelwooddaily.com - July 11 at 5:19 PM
fiscalstandard.com logoGenocea Biosciences Inc (GNCA) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:GNCA)
www.fiscalstandard.com - July 11 at 5:19 PM
investornewswire.com logoIs $40 Within Reach For Genocea Biosciences, Inc. (NASDAQ:GNCA)? - Investor Newswire (NASDAQ:GNCA)
www.investornewswire.com - July 10 at 9:42 AM
News IconHC Stocks Momentum: Baxter International Inc (NYSE:BAX), Genocea Biosciences Inc (NASDAQ:GNCA) - share market updates (press release) (NASDAQ:GNCA)
sharemarketupdates.com - July 8 at 5:14 PM
equities.com logoGenocea Biosciences Inc. (GNCA) Jumps 5.53% on July 06 - Equities.com (NASDAQ:GNCA)
www.equities.com - July 8 at 8:04 AM
News IconTracking Unusual Volume on Shares of: Genocea Biosciences, Inc. (NASDAQ:GNCA) - Engelwood Daily (NASDAQ:GNCA)
www.engelwooddaily.com - July 7 at 8:04 AM
News IconCompany Stock Focus for Genocea Biosciences, Inc. (NASDAQ:GNCA): Which Way Will Shares Head? - Press Telegraph (NASDAQ:GNCA)
presstelegraph.com - July 7 at 8:04 AM
News IconGenocea Biosciences Incorporated (NASDAQ:GNCA) Shorts Decreased by 4.84% After Short Covering - Press Telegraph (NASDAQ:GNCA)
presstelegraph.com - July 6 at 9:58 AM
equities.com logoGenocea Biosciences Inc. (GNCA) Jumps 5.37% on July 04 - Equities.com (NASDAQ:GNCA)
www.equities.com - July 6 at 9:58 AM
publicnow.com logoGenocea to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:GNCA)
www.publicnow.com - July 6 at 8:21 AM
finance.yahoo.com logoGenocea to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:GNCA)
finance.yahoo.com - July 6 at 8:00 AM
News IconShare Performance Recap for: Genocea Biosciences, Inc. (NASDAQ:GNCA) - Press Telegraph (NASDAQ:GNCA)
presstelegraph.com - July 4 at 4:55 PM
investornewswire.com logoGenocea Biosciences, Inc. (NASDAQ:GNCA) Expected to Reach Highs Of $40 - Investor Newswire (NASDAQ:GNCA)
www.investornewswire.com - July 3 at 9:44 AM
News IconHow Many Genocea Biosciences Inc (NASDAQ:GNCA)'s Analysts Are Bullish? - Press Telegraph (NASDAQ:GNCA)
presstelegraph.com - July 3 at 9:44 AM
equities.com logoGenocea Biosciences Inc. (GNCA) Drops 7.24% on June 30 - Equities.com (NASDAQ:GNCA)
www.equities.com - July 2 at 8:12 AM
equities.com logoGenocea Biosciences Inc. (GNCA) is Trading Higher on Unusual Volume for June 29 - Equities.com (NASDAQ:GNCA)
www.equities.com - July 1 at 8:03 AM
News IconGenocea Biosciences, Inc. (NASDAQ:GNCA) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:GNCA)
www.engelwooddaily.com - June 30 at 5:33 PM
News IconCovering the Bases on Genocea Biosciences, Inc. (NASDAQ:GNCA): Where is the Stock Going? - Press Telegraph (NASDAQ:GNCA)
presstelegraph.com - June 30 at 8:05 AM
News IconCheck on Share Volatility: Genocea Biosciences, Inc. (NASDAQ:GNCA) - Engelwood Daily (NASDAQ:GNCA)
www.engelwooddaily.com - June 29 at 8:04 AM

Social

Genocea Biosciences (NASDAQ:GNCA) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff